DE60037626D1 - Immunogene mit repetitiver Peptidsequenzen - Google Patents

Immunogene mit repetitiver Peptidsequenzen

Info

Publication number
DE60037626D1
DE60037626D1 DE60037626T DE60037626T DE60037626D1 DE 60037626 D1 DE60037626 D1 DE 60037626D1 DE 60037626 T DE60037626 T DE 60037626T DE 60037626 T DE60037626 T DE 60037626T DE 60037626 D1 DE60037626 D1 DE 60037626D1
Authority
DE
Germany
Prior art keywords
immunogens
peptide sequences
repetitive peptide
repetitive
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60037626T
Other languages
English (en)
Inventor
Jaulang Hwang
Chia-Tse Hsu
Chun-Jen Ting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academia Sinica
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Application granted granted Critical
Publication of DE60037626D1 publication Critical patent/DE60037626D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60037626T 1999-10-05 2000-05-19 Immunogene mit repetitiver Peptidsequenzen Expired - Lifetime DE60037626D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/412,558 US6838553B1 (en) 1999-10-05 1999-10-05 Peptide repeat immunogens

Publications (1)

Publication Number Publication Date
DE60037626D1 true DE60037626D1 (de) 2008-02-14

Family

ID=23633489

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60037626T Expired - Lifetime DE60037626D1 (de) 1999-10-05 2000-05-19 Immunogene mit repetitiver Peptidsequenzen

Country Status (7)

Country Link
US (2) US6838553B1 (de)
EP (1) EP1090994B1 (de)
AU (1) AU772387B2 (de)
CA (1) CA2304377A1 (de)
DE (1) DE60037626D1 (de)
NZ (1) NZ507368A (de)
TW (1) TW528760B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE529436T1 (de) 2007-04-20 2011-11-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
US8383767B2 (en) * 2008-06-27 2013-02-26 Academia Sinica Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain
US20110256172A1 (en) * 2008-10-14 2011-10-20 The Regents Of The University Of Michigan Epitope-targeted anthrax vaccine
US9226701B2 (en) * 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
HUE059330T2 (hu) 2018-03-08 2022-11-28 Applied Molecular Transport Inc Toxinból származó bejuttatási konstrukciók orális beadásra
MX2021005382A (es) 2018-11-07 2021-11-12 Applied Molecular Transport Inc Vehiculos derivados de cholix para suministro oral de carga util heterologa.
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668255A (en) 1984-06-07 1997-09-16 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
US5830713A (en) 1986-11-04 1998-11-03 Protein Polymer Technologies, Inc. Methods for preparing synthetic repetitive DNA
SE459825B (sv) * 1988-07-18 1989-08-07 Bent Erland Ilon Automatiskt verkande utvaexlingsanordning
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
GB8915019D0 (en) * 1989-06-30 1989-08-23 Matthews Ruth C Medicaments
US5403586A (en) * 1989-08-25 1995-04-04 Biotechnology Australia Ptl Ltd. LHRH-TraTp fusion proteins
CA2083949A1 (en) * 1991-04-02 1992-10-03 Ayre Rubinstein Therapeutic and preventive vaccines for hiv
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
EP0967279B1 (de) * 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik
US5648245A (en) 1995-05-09 1997-07-15 Carnegie Institution Of Washington Method for constructing an oligonucleotide concatamer library by rolling circle replication
AU7718696A (en) * 1995-10-27 1997-05-15 Merck & Co., Inc. Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines
WO1998008874A1 (en) * 1996-08-27 1998-03-05 Chiron Corporation Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
AU731703B2 (en) * 1997-07-11 2001-04-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pseudomonas exotoxin A-like chimeric immunogens
US6287568B1 (en) * 1997-09-09 2001-09-11 The Trustees Of Columbia University In The City Of New York Methods relating to immunogenic dextran-protein conjugates
US6140066A (en) * 1998-03-24 2000-10-31 Lorberboum-Galski; Haya Methods of cancer diagnosis using a chimeric toxin
US6387684B1 (en) * 1999-09-13 2002-05-14 Academia Sinica Topoisomerase 1-mediated DNA delivery
WO2001074383A1 (en) * 2000-04-03 2001-10-11 Uab Research Foundation Chimeric antigen-enterotoxin mucosal immunogens
US20030219459A1 (en) * 2002-01-18 2003-11-27 Cytos Biotechnology Ag Prion protein carrier-conjugates

Also Published As

Publication number Publication date
AU772387B2 (en) 2004-04-29
US6838553B1 (en) 2005-01-04
EP1090994B1 (de) 2008-01-02
EP1090994A2 (de) 2001-04-11
TW528760B (en) 2003-04-21
CA2304377A1 (en) 2001-04-05
AU6250000A (en) 2001-04-12
NZ507368A (en) 2001-06-29
US20030044936A1 (en) 2003-03-06
EP1090994A3 (de) 2001-07-18

Similar Documents

Publication Publication Date Title
NL300939I2 (nl) Benralizumab
NO982097D0 (no) Peptider
NO982098L (no) Peptider
DE60022199D1 (de) Tamponapplikator mit verbesserter greifmöglichkeit
EE200100080A (et) C-hepatiidi inhibiitorpeptiidid
FI970388A (fi) Menetelmä kuvasekvenssien kontrastin parantamiseksi
DE60035736D1 (de) EEPROM mit Redundanz
EE200100374A (et) 1-heterotsükliga asendatud diarüülamiinid
IS2231B (is) Nýjar amínóprópýlfosfínsýrur
IL146451A0 (en) C-terminal protein tagging
DE60042556D1 (de) Für polyepitop-polypeptide kodierende nukleinsäuren
EP1094689A4 (de) Elektrolumineszente vorrichtung
DE60037626D1 (de) Immunogene mit repetitiver Peptidsequenzen
DE60003361D1 (de) Elektrolumineszenzlampe
DE50004258D1 (de) Transportvorrichtung
FR2791348B1 (fr) POLYPEPTIDE Npt2B
DK1230369T3 (da) Polypeptidhormon phosphatonin
IL150458A0 (en) Novel haptotactic peptides
NO20032383L (no) Baneströmforsyningssystem
EP1175130A4 (de) Elektrolumineszierendes element
NO20013933D0 (no) Peptider
AU2001295580A1 (en) Nucleotide sequences which code for the dep67 protein
EP1245955A4 (de) Zytokin-ähnliche peptide
SE0004102D0 (sv) Promoter sequences II
SE0003435D0 (sv) Promoter sequences

Legal Events

Date Code Title Description
8332 No legal effect for de